Skip to main content

Select Drug Profiles

New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine

Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management

Medical Costs Increase as Chronic Kidney Disease Worsens

Value-Based Benefit Design: Reducing Copayment for High-Value Services Maximizes Return on Investment

Cardiometabolic Health

Diabetes Rates Surging Among American Youth

Paying Patients to Change Their Health Behavior Is Effective

Primary Care Physicians Underdiagnose Chronic Kidney Disease in Diabetic Patients

Real-Time Continuous Glucose Monitoring Cost-Effective in Patients with Type 2 Diabetes

Cardiometabolic Health

ORIGIN: Insulin Glargine and Omega-3 Do Not Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes

Cardiometabolic Health

Glycemic Control in Patients with Type 2 Diabetes Significantly Lowers Cardiovascular Disease Risk

Page 196 of 244
Results 1951 - 1960 of 2438